Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK

Biochemical and Biophysical Research Communications
Narasimman GurusamyYoshifusa Aizawa

Abstract

14-3-3 family members are dimeric, phosphoserine binding proteins that regulate signal transduction, apoptotic, and checkpoint control pathways. Recently, cardiomyocyte apoptosis has been characterized in type I diabetes mellitus. In order to study the molecular mechanism underlying diabetes-induced cardiomyocyte apoptosis, we examined the role of 14-3-3 protein and MAPK pathways in transgenic mice with cardiac specific expression of dominant negative 14-3-3eta (DN-14-3-3). p38 MAPK was highly activated 1, 28, and 56 days after diabetes induction by streptozotocin, whereas peak JNK activation was found on day 3 and decreased afterwards. In contrast, ERK1/2 were not activated in diabetic myocardium. Cardiomyocyte apoptosis was peaked on day 3 and decreased on 7, 28, and 56 days. p38 MAPK and JNK activation as well as cardiomyocyte apoptosis were greatly increased in DN-14-3-3 mice relative to non-transgenic mice. Moreover, we found a significant correlation between JNK activation and apoptosis in diabetic myocardium. These results indicate for the first time that 14-3-3 protein plays a critical anti-apoptotic role in diabetic myocardium by inhibiting the JNK pathway.

References

Nov 26, 1987·The New England Journal of Medicine·A S KrolewskiC R Kahn
Jan 1, 1985·Progress in Cardiovascular Diseases·F S Fein, E H Sonnenblick
Sep 1, 1983·The American Journal of Physiology·G N Pierce, N S Dhalla
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G N PierceN S Dhalla
Nov 24, 1995·Science·Z XiaM E Greenberg
Oct 13, 1994·Nature·W J FantlL T Williams
Apr 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·I KomuroY Yazaki
Feb 1, 1996·Coronary Artery Disease·N J Hardin
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·L ZhangH Fu
Sep 16, 1999·The Journal of Clinical Investigation·J H RogersA J Muslin
Mar 23, 2000·Cardiovascular Research·G Z Feuerstein, P R Young
Apr 26, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·F FiordalisoJ Kajstura
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·H FuS C Masters
Jul 20, 2000·Journal of Molecular and Cellular Cardiology·K Mackay, D Mochly-Rosen
Sep 23, 2000·American Journal of Physiology. Endocrinology and Metabolism·W LiuW L Lowe
Jan 11, 2000·Circulation Research·A FrustaciP Anversa
Mar 10, 2001·The Journal of Biological Chemistry·H ZhangS Pelech
Jan 12, 2002·The Journal of Biological Chemistry·Hiroki AokiSeigo Izumo

❮ Previous
Next ❯

Citations

Apr 20, 2006·Clinical and Experimental Pharmacology & Physiology·Ming HeZhijun Luo
Jun 25, 2010·Clinical and Experimental Pharmacology & Physiology·Jia-Liang LiangXi-Yong Yu
Mar 3, 2007·Biological & Pharmaceutical Bulletin·Kenichi WatanabeYoshifusa Aizawa
Jan 28, 2014·Pharmacology & Therapeutics·Karina HuynhRebecca H Ritchie
Mar 18, 2008·Biochemical Pharmacology·Rajarajan A ThandavarayanYoshifusa Aizawa
Oct 24, 2006·Experimental Cell Research·Merit E Reyes-ReyesSteven K Akiyama
Aug 27, 2009·Acta Physiologica Hungarica·Kenichi WatanabeY Aizawa
Jun 22, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Flori R SariKenichi Watanabe
Dec 20, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Rajarajan A ThandavarayanKenichi Watanabe
Jul 21, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Rajarajan A ThandavarayanYoshifusa Aizawa
Nov 9, 2010·The Journal of Pharmacy and Pharmacology·Wawaimuli ArozalYoshifusa Aizawa
Feb 17, 2018·Circulation Research·Guanghong JiaJames R Sowers
Aug 28, 2018·Oxidative Medicine and Cellular Longevity·Meifang ZhuBo Yi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis